Minnesota State University, Mankato

Cornerstone: A Collection of Scholarly
and Creative Works for Minnesota
State University, Mankato
All Theses, Dissertations, and Other Capstone
Projects

Theses, Dissertations, and Other Capstone
Projects

2020

Impact of Non-Pharmacological Treatment Methods and Lifestyle
Modification on Multiple Sclerosis Symptoms and Progression
Emily Moret
Minnesota State University, Mankato

Follow this and additional works at: https://cornerstone.lib.mnsu.edu/etds
Part of the Nervous System Diseases Commons, Nursing Commons, and the Rehabilitation and
Therapy Commons

Recommended Citation
Moret, E. (2020). Impact of non-pharmacological treatment methods and lifestyle modifications on
multiple sclerosis symptoms and progression [Master’s alternative plan paper, Minnesota State University,
Mankato]. Cornerstone: A Collection of Scholarly and Creative Works for Minnesota State University,
Mankato. https://cornerstone.lib.mnsu.edu/etds/984/

This APP is brought to you for free and open access by the Theses, Dissertations, and Other Capstone Projects at
Cornerstone: A Collection of Scholarly and Creative Works for Minnesota State University, Mankato. It has been
accepted for inclusion in All Theses, Dissertations, and Other Capstone Projects by an authorized administrator of
Cornerstone: A Collection of Scholarly and Creative Works for Minnesota State University, Mankato.

1

Impact of Non-Pharmacological Treatment Methods and Lifestyle Modification on
Multiple Sclerosis Symptoms and Progression
Emily Moret
School of Nursing, Minnesota State University, Mankato
NURS 695: Alternative Plan Paper
Dr. Rhonda Cornell
May 1, 2020

2

Abstract
Multiple sclerosis is a chronic, neurological, autoimmune condition that is characterized by
unpredictable demyelination of the central nervous system. Multiple sclerosis remains one of the
most debilitating neurological diseases for young adults, affecting an average of 2.5 per 100,000
people worldwide.
The objective of this research was to further assess the efficacy of non-pharmacological
treatment methods for symptom management and disease progression for multiple sclerosis. A
systemic literature review was conducted using 4 research databases: American Search Premier,
Medline, Cochrane, and CINAHL. Studies were included if they addressed nonpharmacological
treatment approaches to multiple sclerosis. A total of 21 research articles were used to assess
inclusion or exclusion criteria.
What the research concluded was that there was not definitive evidence to prove that any
non-pharmacological treatment method would guarantee a decrease in disability or increase in
overall quality of life for patients with multiple sclerosis. However this body of research did
show that non-pharmacological interventions could provide some benefit and none of these nonpharmacological treatment methods were harmful, thus validating the safety and potential benefit
to be implemented in practice. Much more research needs to be conducted to look specifically at
different nonpharmacological treatment approaches for the management of multiple sclerosis as
varying symptoms make it difficult to pinpoint the exact benefit that each nonpharmacological
approach may have.
Keywords: multiple sclerosis, non-pharmacological, treatment, lifestyle modification,
disease progression, smoking, diet, exercise
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Impact of Non-Pharmacological Treatment Methods and Lifestyle Modification on
Multiple Sclerosis Symptoms and Progression
Multiple sclerosis is a chronic autoimmune, condition that is characterized by
inflammation and demyelination of the central nervous system (Amatya et al., 2013). Multiple
sclerosis occurs more commonly in women. Multiple sclerosis is an autoimmune disorder that
has an unclear etiology, and can be associated with long-term effects, complications and,
decreased quality of life. Multiple sclerosis has the capacity to cause severe disability in those
affected by the disease. There are different forms of multiple sclerosis, each with varying degrees
of disability. Different forms of multiple sclerosis include relapsing remitting, primary
progressive, and secondary progressive. Relapsing remitting forms of multiple sclerosis consist
of periods of inflammation and exacerbation followed by periods of returning to baseline, or
remission. Primary and secondary progressive forms of multiple sclerosis occur when a person
slowly progress in their disease process without the ability to return to their baseline functioning
(Amatya et al., 2013). Secondary progression typically occurs in adults after they have had
relapsing-remitting multiple sclerosis. At this stage, the patient will continue to have relapses but
will not experience remission. Primary progressive forms of multiple sclerosis occur initially
when the diagnosis is not consistent with relapsing-remitting. In this form of multiple sclerosis,
the initial disease course consists of relapse and absence of remission. Once a person has a
diagnosis of multiple sclerosis, they typically have a prolonged life period of at least 40 more
years. Because of this, it is likely for a person to have a prolonged disease process and
progression of disability, making it imperative that patients with multiple sclerosis obtain
treatment to prevent severe disability and improve quality of life (Amatya et al., 2013).
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In recent decades, there has been a dramatic increase in the amount of effort that has been
placed on assessing different types of treatment modalities for multiple sclerosis. Treatment for
multiple sclerosis can come in a variety of forms. Pharmacological treatment methods have been
extensively studied and are ever changing. However, non-pharmacological treatment approaches
to the management of multiple sclerosis is an area of medicine that is much less researched.
There is a variety of non-pharmacological treatment options that had been researched for
symptom management for multiple sclerosis. The objective of this literature review is to examine
the evidence pertaining to the efficacy of non-pharmacological treatment methods for symptom
management and impact on the disease progression of multiple sclerosis.
Background
The exact cause of multiple sclerosis remains unknown however environmental and
immunological factors may play a part. Over the past decades, there has been a rapid increase in
the incidence and prevalence of multiple sclerosis throughout the world. Some think that this
may be due to the change in dietary and lifestyle habits, although there is no definitive cause of
the increasing number of patients with multiple sclerosis (Matveeva et al., 2018). Environmental
factors that have been attributed to the development of multiple sclerosis include inadequate
vitamin D levels, tobacco use, obesity, genetic predisposition, infection with the Epstein Barr
virus, and geographic location (Matveeva et al., 2018). Worldwide, multiple sclerosis affects
over 2.5 million people. Multiple sclerosis is the most present in the northern hemisphere. There
is currently no cure for multiple sclerosis. However, measures can be implemented to help with
symptom management.
Clinical manifestations for patients with multiple sclerosis can be variable and dependent
on the person. Some of these manifestations can include vision loss, weakness, ataxia, spasticity,

5

tremors, sensory loss, cognitive impairment, and bowel and bladder dysfunction (Amatya et al.,
2013). Pharmacological methods have proven to help with symptom relief and disease
progression. However, non-pharmacological treatment methods can also help with symptom
management and prevention of relapses. With the increasing numbers of multiple sclerosis cases
worldwide, there has also been an increasing interest and amount of research conducted on
treatment options. As a result, there has been an increasing amount of evidence on nonpharmacological treatment for prevention of multiple sclerosis progression. Much of the research
on non-pharmacological treatment is also focused on quality of life. Some of the nonpharmacological treatments that have been heavily researched include diet, exercise, and
smoking cessation. When measuring the outcomes of non-pharmacological treatment, data is
often collected from subjective report. Symptoms measured subjectively include spasticity,
fatigue, pain relief, and overall quality of life.
Much of the focus on autoimmune conditions and their treatment relies on
pharmacological management. The significance of non-pharmacological management in the
treatment of multiple sclerosis is also gaining relevance with increasing research. Many factors
go into treatment for multiple sclerosis, some of which are difficult to obtain due to cost and
availability. The benefit of non-pharmacological treatment is the ease of accessibility and
affordability for patients. With the increasing rates of patients being diagnosed with multiple
sclerosis, there is an increased importance that is being placed on treatment options. In the
primary care setting, management will be collaborative and based on patient preferences,
providing education, and sharing clinical evidence.
Recognizing the importance of managing symptoms and delaying disease progression can
be pivotal for the health outcomes of the patients diagnosed with multiple sclerosis. When
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assessing outcomes for non-pharmacological treatment for patients with multiple sclerosis, it is
important to ask the questions about if treatment is effective in minimizing impairment, effective
in minimizing the burden of care, an improving quality of life (Amatya et al., 2013).
Clinical Question
Based on the clinical significance of this area of interest, a Population-Intervention-Outcome
(PIO) question was formatted to help guide a systemic literature review (Melnyk & FineoutOverholt, 2015). Among adults living with multiple sclerosis (P), how do non-pharmacological
treatment methods and/or lifestyle modification (I) impact disease progression and symptom
management (O)? The working hypothesis is that non-pharmacological treatment methods for
multiple sclerosis will aid in symptom management and alter disease progression for patients
who carry an established diagnosis.
Clinical Significance for Advanced Practice
A multi-disciplinary approach is needed to manage care for patients with the diagnosis of
multiple sclerosis. The modalities that are involved in treatment can be rather complex. To this
point, multiple sclerosis remains one of the most challenging neurological diseases to understand
and treat (Matveeva et al., 2018). There has been an increase in the amount of knowledge that is
known about mechanisms that may trigger and drive multiple sclerosis allowing for
individualized therapy in the advanced practice setting (Matveeva et al., 2018). Providers must
place increased accountability on patients with multiple sclerosis for managing their care and
engaging in positive health promoting behaviors. In the advanced practice setting, motivational
interviewing, educating, and encouraging healthy behavior through non-pharmacological
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approach can lead to better health outcomes and improved quality of life for patients with
multiple sclerosis.
Methods
A comprehensive literature review was conducted between 10/1/2019 and 11/15/2019.
Databases that were selected for reviewed included Academic Search Premier (ASP),
Cumulative Index of Nursing and Allied Health Literature (CINAHL), Medline, and Cochrane
Database of Systematic Reviews. These databases were selected in order to provide a
comprehensive review of the available literature. Articles were limited to full text, peerreviewed, and abstract available. All articles were published after the year of 2006. For
reference, refer to Appendix A. Keywords that were used for research included “multiple
sclerosis,” “non-pharmacological,” “treatment,” “smoking,” “exercise,” “diet,” “lifestyle,”
“lifestyle modification,” and “disease progression.” For specific keyword combinations and
yielded results for every database assessed, reference Appendix B. For every keyword
combination, results were reviewed if there were 10 or less results. A total of 21 studies were
identify as potentially pertinent to the clinical question based on review of title and abstract;
these studies were further reviewed for inclusion and exclusion criteria.
Inclusion and Exclusion
Articles that were related to non- pharmacological methods for disease management were
included. Studies were eliminated if they focused only on pharmacological management. An
extensive amount of research was conducted on lifestyle modifications including smoking, diet,
and exercise. Studies that focused on psychological interventions were excluded, as these were
more pertinent to quality of life rather than disease alteration. Another study that was often
brought up was done over a five-day course at a residential treatment center (Hadgkiss et al.,
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2013). These studies were excluded as they were short-term and did not give indications of
disease modification, but rather focused on quality of life. Articles that addressed nonpharmacological methods for treatment of symptoms, such as chronic pain, fatigue, or spasticity,
were included. All studies that only addressed quality of life as an indicator of nonpharmacological intervention were excluded. Of the 21 studies that were examined through
review of the abstracts, 13 met inclusion criteria. See Appendix C for detailed information
related to the rationale for each study that was included or excluded. See Appendix D for the data
abstracted from the studies included in the systemic review. Each study was fully reviewed for
findings pertinent to the clinical question.
Literature Review
There have been a multitude of studies that have been completed on non-pharmacological
treatments for multiple sclerosis. Emerging themes among the research include lifestyle
modification of diet, exercise, and smoking cessation. Along with that, there are individualized
studies that focus on more specific non-pharmacological treatments such as the use of
transcutaneous electrical nerve stimulation and hyperbaric oxygen therapy. This literature review
will identify the findings in each of these sub-categories of interest.
Non-Pharmacological Treatments
Muscle spasticity is among one of the many debilitating side effects of the progression of
multiple sclerosis. Spasticity causes things such as stiffness, spasms, or tightness in any of the
extremities. On average 60 to 80% of patients with multiple sclerosis will experience spasticity
at some point during their disease process (Amatya et al., 2013). Spasticity can be one of the
leading causes of disability and instability for patients with multiple sclerosis. Long term
complications of spasticity can include muscle contractures, pain, pressure injuries, and inability
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to adequately perform activities of daily living. This associated symptom of multiple sclerosis is
extremely challenging to manage. In one study, spasticity management was investigated through
the evaluation of nine randomized control trials (Amatya et al., 2013). This study investigated
physiotherapy, electromagnetic therapy, and transcutaneous electrical nerve stimulation as nonpharmacological treatment methods for spasticity in patients with multiple sclerosis. When
training muscle spasticity, the goal for management is to create goals and rehabilitation in order
for patients to maintain a functional quality of life (Amatya et al., 2013). Due to the risks, costs,
access issues, and unpredictable results associated with surgical procedures to treat spasticity,
nonpharmacological interventions are often the mainstay of treatment and management. The
biggest barrier regarding current evidence in research related to spasticity for patients with
multiple sclerosis is the lack of known benefits (Amatya et al., 2013). This study examined
rehabilitation programs in the inpatient, outpatient, and in home settings. The study concluded
that there was an extreme amount diversity in the outcomes.
Transcutaneous Electrical Nerve Stimulation
Amatya et al. (2013) also assessed transcutaneous electrical nerve stimulation
intervention. There was no statistically significant difference between patients who received
therapy versus patients who did not receive therapy and their overall report of reduction in
muscle spasm (Amatya et al., 2013). Researchers concluded, there was not enough evidence to
support the routine use of transcutaneous electrical nerve stimulation for the treatment of
spasticity (Amatya et al., 2013). However, the quality of this evidence is limited due to the
inadequate amount of studies in research that has been conducted. This study did highlight gaps
in the literature that are present when attempting to draw conclusions from this research on nonpharmacological treatment for spasticity (Amatya et al., 2013).
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Hyperbaric Oxygen Therapy
When conducting research on non-pharmacological treatment approaches to multiple
sclerosis, one area was also mentioned that was not quite as common. This was hyperbaric
oxygen therapy for the decrease in disease progression. This study was a meta-analysis that
looked at hyperbaric oxygen therapy and the benefits it may have in slowing the disease process.
A total of 9 trials were looked at in this article with a total of 504 participants (Bennett et al.,
2011). Two of the trials did show a positive result in the decreasing of multiple sclerosis
development when using hyperbaric oxygen therapy. The remaining 7 trials reported no evidence
of treatment effect (Bennett et al., 2011). Due to the lack of evidence there is not enough
consistent support for the benefit of hyperbaric oxygen therapy for the treatment of multiple
sclerosis. The cost is extremely high as well and may not be justified due to the lack of evidence.
However given there was positive benefit seen, more research is needed to validate the routine
use of hyperbaric oxygen therapy for multiple sclerosis (Bennett et al., 2011).
Lifestyle Modification
Tobacco Cessation
Smoking tobacco and smoking cessation is a lifestyle factor that has been studied with
multiple sclerosis. One meta-analysis of 11 studies assessed the relationship of tobacco use to
worsening disability in multiple sclerosis patients (Heydarpour et al., 2018). Disability due to
smoking was measured using an expanded disability status scale (EDSS) or the multiple sclerosis
severity scale (MSSS). According to some of the research included in the meta-analysis, there
was significant disability in patients with multiple sclerosis who smoked tobacco and some
studies revealed no significant disability (Heydarpour et al., 2018). One of the studies that was
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assessed in this meta-analysis looked at the pathophysiology of the respiratory system and
patients with multiple sclerosis. This study found that patients with multiple sclerosis inevitably
have a weakened immune systems and pulmonary function. Because of this, their lungs are also
weekend. The study found that patients with multiple sclerosis that smoke had a significant
reduction of CD4+ cells compared to other smokers who do not have multiple sclerosis. This
leads to decrease clearance of smoke particles and an increase in inflammatory response due to
smoking in patients with multiple sclerosis (Heydarpour et al., 2018).
This meta-analysis concluded was that smoking does increase disability for patients with
multiple sclerosis. However, it also concluded that it did not increase the risk of worsening the
severity of multiple sclerosis (Heydarpour et al., 2018). What this means is that for patients with
severe disability due to multiple sclerosis, smoking has a strong likelihood of making that
disability worse. However, for patients with multiple sclerosis and no significant disability,
smoking may not make the multiple sclerosis symptoms develop or worsen (Heydarpour et al.,
2018). Since this article was published, further studies have been conducted that assess smoking
cessation and multiple sclerosis. However, many of these studies focus collectively on lifestyle
change rather than isolating smoking cessation thereby revealing a gap in the research literature
(Heydarpour et al., 2018). Along with that, there lacks a standardized way to assess disability
due to smoking which has led to a variety of study methods related to smoking and multiple
sclerosis.
Diet
Dietary modifications are another lifestyle consideration for multiple sclerosis symptoms
that is very prevalent in research. In one study, the researcher implemented a five day residential
workshop that promoted a low-fat, plant based, seafood, high vitamin D, omega-3
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supplementation diet (Marck et al., 2018). The participants in the study had to have had
experienced one relapse in the prior year. A questionnaire was used to assess dietary habits.
After this workshop, the participants were assessed at the one year and three year mark. There
were a total of 76 participants at the one year mark in 78 participants at the three year mark
(Marck et al., 2018). The majority of these patients, 73%, had a diagnosis of relapsing-remitting
multiple sclerosis What the study found was that there were improvements in health outcomes
one year after the intervention and there was substantial and sustained improved health outcomes
three years after the workshop. The goal of this study was to assess if lifestyle changes were
maintainable for patients with multiple sclerosis. The study concluded that, over time, patients
with multiple sclerosis were able to sustain healthy lifestyle choices that led to a decrease in their
overall disability. One of the biggest limitations of this study was the small sample size as well
as all of the data being self-reported (Marck et al., 2018).
One study looked at overall brain atrophy that was due to poor diet for patients with
multiple sclerosis (Jakimovski et al., 2019). This study compared patients with multiple sclerosis
to healthy controls. The participants in the study had to implement lifestyle-based behavior and
their brain was imaged through MRI over a five-year period. What the study found was that
patients with multiple sclerosis who had an unhealthy diet had a higher accrual of brain lesions
over a five year period (Jakimovski et al., 2019). The study looked at the Mediterranean diet and
the effects that it may have on multiple sclerosis. This diet includes fruits, vegetables, whole
grains, and reduced sugar and red meat (Jakimovski et al., 2019). Given that poor diet was
correlated with higher lesion accrual, and there were weaker associations with diet alcohol and
tobacco, it could imply that there is an independent process that diet contributes to brain atrophy
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for patients with multiple sclerosis. What this study concluded was that healthy lifestyle caused a
decrease in brain atrophy and lesion accrual (Jakimovski et al., 2019).
Dietary factors and obesity have been known to play a significant role for patients with
multiple sclerosis. In one study, the westernized diet was investigated as it may play a significant
role in the development and worsening of multiple sclerosis. The westernized diet is high in salt,
fatty acids, flavonoids, and saturated fats. A diet high in salt has been correlated to enhance
disease exacerbation and new lesion development. Salt also can affect T cells which alter the
macrophage response (Matveeva et al., 2018). This causes a suppression of the antiinflammatory properties that a macrophage possesses. The role that fats play in the development
and progression of multiple sclerosis is linked to their effect on inflammation and increasing
relapse risk (Matveeva et al., 2018). Flavonoids play a role in multiple sclerosis development in
that the suppress monocytes and limit the uptake of myelin by macrophages. However, there is
mixed evidence because certain flavonoids, such as scutellarin, may aid in central nervous
system repair (Matveeva et al., 2018). What this study concluded was that more research should
be done on the specific mechanisms that different types of food in the westernized diet may
contribute to the development and progression of multiple sclerosis (Matveeva et al., 2018).
Exercise
When assessing approaches to lifestyle modification, exercise is a topic that is often
studied. There is extensive research examining the relationship between exercise and its effect on
overall functioning for patients with multiple sclerosis. One study looked at formal exercise in a
variety of exercise techniques and their ability to maintain and improve functional capacity for
patients with multiple sclerosis (White & Dressendorfer, 2004). One of the major things that was
assessed was muscle strength as well as mobility. Disability for patients with multiple sclerosis
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was often related to a reduced mobility, poor balance, abnormal gait, and muscle weakness.
Exercise and strength training can play a significant role in decreasing disability for patients with
multiple sclerosis. Much of the research that is conducted on exercise related to multiple
sclerosis has to do with decreasing disability and improving quality of life. Another significant
thing to think about for patients with multiple sclerosis is their long-term use of corticosteroids.
Corticosteroids have been shown to decrease bone density in patients with and without multiple
sclerosis. Given that patients with multiple sclerosis are already at an increased risk of premature
osteoporosis, bone health is very important. Strength training and resistance training can help to
preserve bone density for patients with multiple sclerosis with the hope of decreasing the
likelihood of osteopenia, osteoporosis, or skeletal related disability. When looking at an exercise
program for patients with multiple sclerosis it should be carefully considered with physical
limitation taken into consideration. Physical therapy is another option that may be used when
formulating an exercise plan for patients with multiple sclerosis. When looking at this study, the
biggest limitation is lack of randomized control trials comparing patients who exercise versus
patients who do not. There is also an increase need for further research to be conducted on the
role that specific exercise routines play in the hindering of multiple sclerosis development
(White & Dressendorfer, 2004).
Another study specifically focusing on activity was conducted. The studies assessed
walking intensity and walking activity as a mechanism for preventing progression of multiple
sclerosis. This study used this step watch activity monitor to assess the number of steps that were
taken by patients who have had multiple sclerosis. The study looked at step count, walking
intensity, and walking duration (Neven et al., 2016). What this study found was that patients with
multiple sclerosis were not meeting the recommended duration or intensity of walking every day.
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In order to achieve benefits from walking the intensity and duration needs to be high enough
(Neven et al., 2016). Another thing to consider for patients with multiple sclerosis is their
potential inability to sustain walking for long periods of time. What the study concluded was that
patients with multiple sclerosis may be active but are not active enough to have significant
benefit from walking. The problem with this is that some patients are unable to walk for a
sustained period due to fatigue, making them outliers in the study (Neven et al., 2016). The
biggest drawback in the study is that it is difficult to often assess stamina for patients with
multiple sclerosis due to other contributing factors such as fatigue.
Other studies assessed fatigue related to multiple sclerosis and interventions that could be
completed to aid in the relief of fatigue. As mentioned with exercise, fatigue can be a significant
barrier for treatment. Fatigue is very common for patients with multiple sclerosis so assessing
daily fatigue is important when formulating an exercise plan Treating fatigue can lead to overall
positive health benefits for patients with multiple sclerosis. In one study, aerobic exercise,
strength, cooling methods, and yoga was shown to have a positive effect on fatigue in patients
with multiple sclerosis (Pozzilli et al., 2006). Both depression and fatigue can negatively affect
cognitive development for patients with multiple sclerosis. In turn, this can have a significant
effect on quality of life. Another study thoroughly discussed pharmacological interventions to
manage fatigue for patients with multiple sclerosis. This study also looked at
nonpharmacological interventions such as physical exercise for the treatment of fatigue. As
mentioned previously, this may be controversial because exercise may help with fatigue but a
patient with multiple sclerosis may not be able to exercise due to fatigue. What the study found
was that there was a significant lack in protocols and evidence related to the treatment of fatigue
for patients with multiple sclerosis (Brenner & Piehl, 2016).

16

Another study looked at positive role that lifestyle played for overall well-being for
patients with multiple sclerosis. This study used a variety of screening tools that assessed mental
functioning, sleep, fatigue, stress, and disability management (Strober et al., 2018). This study
looked at overall wellness and using a holistic approach to increase overall quality of life for
patients with multiple sclerosis (Strober et al., 2018). What the study found was that lifestyle
habits including diet, exercise, social participation, and intellectual activities were positively
correlated with overall well-being for patients of multiple sclerosis (Strober et al., 2018).
Because of this, there was a decrease in overall disease burden. The biggest drawback to this
study was that data was collected by subjective questionnaire rather than objective assessment.
Along with that, it was a small sample size consisting of only 248 participants (Strober et al.,
2018).
Discussion
Multiple sclerosis is one of the most debilitating autoimmune disorders. There has been
an extensive amount of new research that has been conducted on different types of treatment
options. As a result of this research there is a variety of findings based on varied methods and
interventions studied. When conducting research on non-pharmacological treatment, topics that
were consistently discussed included smoking, exercise, dietary, and overall healthy lifestyle.
There were also outliers in the research that assessed different nonpharmacological treatment
such as hyperbaric oxygen therapy and transcutaneous electrical nerve stimulation. When
looking at multiple sclerosis, there is such an array of symptoms that a patient may experience.
Because of this, there is an array of non-pharmacological approaches that may also be completed
to help with those symptoms.
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In terms of non-pharmacological treatment, some research findings were more
convincing than others. Healthy lifestyle in the form of smoking cessation, exercise, and dietary
restrictions did prove to be beneficial for patients with multiple sclerosis. Much of the studies
that were completed on lifestyle modification concluded that, when smoking cessation, healthy
diet, and exercise take place, a patient with multiple sclerosis was able to have some form of
symptom relief. Although much of the research is limited, or focused on one specific area, there
did prove to be benefit. Hyperbaric oxygen therapy is a newer area of research and has been
beneficial to some patients though not found to be statistically significant. The common
characteristics of these patients was that they had a definite diagnosis of multiple sclerosis, had
not had periods of exacerbations in the past three to twelve months, had received no recent
immunotherapy, and had no other contraindications to receiving hyperbaric oxygen therapy.
(Heard & Bennett, 2011). Transcutaneous electrical nerve stimulation is more aimed at symptom
management rather than disease progression or modification. Although it may help with the
short-term symptom management, it has not been proven to provide any long-term beneficial
effects.
There is still an extensive amount of research that needs to be done when assessing
nonpharmacological treatment approaches for patients with multiple sclerosis. When looking at
lifestyle factors, the most commonly researched areas including tobacco use, diet, and exercise,
though there remains a significant amount of discrepancy in the research. However, when
looking at this body of research, the one commonality was that non-pharmacological treatment
interventions and recommended lifestyle modifications never caused worsening of symptoms or
disease progression. Considering this, it does reveal that nonpharmacological treatment methods
are safe, easy, cost effective, and have the potential for providing some benefit.
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Implications for Practice
In the field of research for non-pharmacological treatment and lifestyle modification
approaches to multiple sclerosis, there is still much research that needs to be completed. When
considering recommendations, the first would be to increase research on different types of
exercise and the benefits that it may have for decreasing disability for patients with multiple
sclerosis as it has been proven to be beneficial. Currently, there is an array of evidence that
provides evidence that exercise can be beneficial though not enough evidence to fully support
one type of exercise over another. When considering walking and fatigue management, more
research should be conducted on types of exercise that may be beneficial for patients who are
immobile due to their high level of disability. If a patient with multiple sclerosis has significant
disability, it is important to investigate what types of exercise may be completed by those
patients that may be beneficial for preventing further disability and improving quality of life.
The biggest problem in research for non-pharmacological treatment approaches to
multiple sclerosis is the variety of symptoms in disability that each patient may face. There
should be more research conducted on dietary contributions and factors that may play a part in
the development and progression of multiple sclerosis. Much of the research that is currently
available focuses on how to improve symptoms rather than how to prevent multiple sclerosis
from occurring due to healthy diet, or if that is even possible.
Research for smoking tobacco during multiple sclerosis is abundant. Research does
support that smoking cessation may decrease the severity of disability for patients with multiple
sclerosis. However, it does not conclude that smoking sensation at the beginning of a multiple
sclerosis diagnosis will alter the disease progression. More research should be conducted on the
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overall effect that smoking tobacco has on the development and progression of multiple
sclerosis, rather than just effect it has on the overall disability.
When looking at nonpharmacological treatment approaches to multiple sclerosis, the
biggest benefit is that these interventions have not been found to be harmful for patients with
multiple sclerosis. Exercise, lifestyle changes, and smoking sensation are beneficial in all
patients whether they have multiple sclerosis or not. It is important to educate patients that these
interventions may or may not aid in symptom management or disease progression of multiple
sclerosis, but they are beneficial for improving overall health.
Conclusion
Multiple sclerosis is an autoimmune, demyelinating, central nervous system disease. It
can affect people throughout their lifetime and be detrimental to their quality of life. The field of
research for multiple sclerosis is ever changing with new medications constantly available.
However, at this point there is no cure for multiple sclerosis. Because of that,
nonpharmacological treatment approaches can be used in combination with pharmacological
treatment approaches to aid in overall quality of life and lack of disease progression.
There is an overall lack of evidence available supporting the use of non-pharmacological
treatments and lifestyle modifications for multiple sclerosis. There is a gap in the literature in
education that may be provided to patients that is concrete and evidence based. Due to the lack of
harmful side effects, patients with multiple sclerosis should be provided with nonpharmacological options to manage their symptoms and lessen disability while also explaining
that they may or may not be beneficial when looking strictly at their multiple sclerosis, as well as
educating on the possible benefits that they may experience.
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Appendix A
Database Search Description
Database

Restrictions Added
to Search

Dates included in
database

General Subjects
covered by database

Academic Search
Premier (ASP)

Full Text, Academic
Journals, Peer
Reviewed

2006-2019

Provides citations and
abstracts to articles, as
well as full text of
articles

CINAHL

Full Text, Academic
Journals, Abstract
Available

2006-2019

Provides full text
access to e-books
about nursing and 29
core nursing journals.
Also provides
citations and abstracts
to articles, books,
dissertations,
proceedings, and
other materials about
all aspects of nursing
and allied health

Medline

Full text, Peer
Reviewed

2006-2019

Provides citations and
abstracts to articles
covering

2006-2019

Evidence-based data
that contains full text
articles, as well as
protocols focusing on
the effects of
healthcare.

Cochrane Database of Full Text
systematic Reviews
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Appendix B
Data Abstraction Process
Key Words

Hits in
ASP

Hits in
CINAHL

Hits in Medline

Hits in
Cochrane

“Multiple Sclerosis”
and “Nonpharmacological”

8*

4*

4*

2*

“Multiple Sclerosis”
and “Treatment”

5,550

1,075

71

16

“Multiple Sclerosis”
and “Smoking”

130

28

613

0

“Multiple Sclerosis”
and “Exercise”

921

569

1585

5*

“Multiple Sclerosis”
and “Diet”

185

68

821

1*

“Multiple Sclerosis”
and “Treatment” and
“Nonpharmacological”

8*

4*

55

0

“Multiple Sclerosis”
and “Lifestyle”

214

111

345

0

“Multiple Sclerosis”
and “Lifestyle
Modification”

22

8*

36

0

“Multiple Sclerosis”,
“Disease Progression”
and “Nonpharmacological”

1*

0

13

0

*-Indicates articles reviewed for match with systematic review inclusion criteria
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Amatya, B., Young, J., Khan, F., &
Amatya, B. (2018). Nonpharmacological interventions for
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Amatya, B., Khan, F., La Mantia,
L., Demetrios, M., Wade, D. T., &
Amatya, B. (2013).
Nonpharmacological interventions
for spasticity in multiple sclerosis.
Cochrane Database of Systematic
Reviews, (2).
Bennett, M. H., Heard, R., &
Bennett, M. H. (2011). Hyperbaric
oxygen therapy for multiple
sclerosis. Cochrane Database of
Systematic Reviews, (8).

Included Rationale
or
Excluded

Included

Included

Included

Non-pharmacological methods for chronic
pain management for patients with MS

Assess the effectiveness of nonpharmacological interventions for the
treatment of spasticity in adults with MS

Hyperbaric oxygen therapy for slowing the
disease process of MS

Brenner, P., & Piehl, F. (2016).
Fatigue and depression in multiple
Included
sclerosis: Pharmacological and nonpharmacological interventions. Acta
Neurologica Scandinavica
Supplementum. 134, 47-54.

Non-pharmacological approaches to
symptom management and fatigue in
patients with MS

Messinis, L., Kosmidis, M. H.,
Lyros, E., & Papathanasopoulos, P.
(2010). Assessment and
rehabilitation of cognitive
impairment in multiple sclerosis.
International Review of Psychiatry,
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Neate, S. L., Taylor, K. L., Jelinek,
G. A., De Livera, A. M., Simpson,
J. S., Bevens, W., & Weiland, T. J.
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Focuses on partners of people living with
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(2019). On the path together:
Experiences of partners of people
with multiple sclerosis of the
impact of lifestyle modification on
their relationship. Health & Social
Care in the Community, 27(6),
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Hadgkiss EJ, Jelinek GA, Weiland
TJ, Rumbold G, Mackinlay CA,
Gutbrod S, & Gawler I. (2013).
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outcomes at 1 and 5 years after a
residential retreat promoting
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Heydarpour, P., Manouchehrinia,
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Abdolalizadeh, A., Lakeh, M.
Moradi, & Sahraian, M. A. (2018).
Smoking and worsening disability
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analysis. Acta Neurologica
Scandinavica, 138(1), 62–69.

Excluded

Quality of life after 5-day stay at residential
retreat where non-pharmacological
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Excluded

Meta-analysis on smoking and worsening
disability for patients with diagnosed
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Jakimovski, D., WeinstockGuttman, B., Gandhi, S., Guan, Y.,
Included
Hagemeier, J., Ramasamy, D. P.,
Fuchs, T., Browne, R., Bergsland,
N., Dwywe, M., Ramanathan, M.,
Zivadinov, R. (2019). Dietary and
lifestyle factors in multiple sclerosis
progression: Results from a 5-year
longitudinal MRI study. Journal of
Neurology, 266(4), 866–875.

Lifestyle risks studied over 5 year
longitudinal study assessing lifestyle on MS
disease progression

Jelinek, G. A., De Livera, A. M.,
Marck, C. H., Brown, C. R., Neate,
S. L., Taylor, K. L., & Weiland, T.
J. (2016). Associations of lifestyle,
medication, and socio-demographic
factors with disability in people

Focuses on heathy lifestyle and the
association with disability with an
international MS sample. Did not specify
interventions that were made, but rather
lifestyle modifications as a whole.
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27

with multiple sclerosis: An
international cross-sectional study.
PLoS ONE, 11(8), 1–12.
Marck, C. H., De Livera, A. M.,
Brown, C. R., Neate, S. L., Taylor,
K. L., Weiland, T. J., Hadgkiss, E.,
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disability. Neurological Sciences,
37(9), 1483–1490.
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Assess health outcomes 3 years after
lifestyle modification interventions
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Excluded
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Excluded

Assess the impact of the western diet on the
progression and development of MS

Assess the role of already existing
comorbidities on the progression of MS

Investigate the step count for patients with
MS to assess the amount of time and
intensity that patients with MS are
exercising

Assess quality of life for patients with MS
who have high BMI, smoke, or consume
alcohol.

28

Health Study. Neurological
Sciences, 26(5), 334–339.
Pozzilli, C., Sbardella, E., de
Giglio, L., & Tomassini, V. (2006).
Treatment of multiple sclerosisrelated fatigue: Pharmacological
and non-pharmacological
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positive lifestyle activities on
mood, cognition, well-being, and
disease characteristics in multiple
sclerosis. Applied
Neuropsychology: Adult, 25(4),
304–311.

Included

Excluded

Excluded

Included

Thomas, P. W., Thomas, S., Hillier,
C., Galvin, K., Baker, R., &
Excluded
Thomas, P. W. (n.d.). Psychological
interventions for multiple sclerosis.
Cochrane Database of Systematic
Reviews, (1).

Non-pharmacological treatment for fatigue
management compared to pharmacological
management

Qualitative cognitive debriefing study done
via patient questionnaire looking at quality
of life

Lifestyle modifications to increase ability to
complete physical activity

The use of adjunct lifestyle modifications
for severity and frequency of MS relapses

Assess the effectiveness of psychological
interventions for patients with MS.

29

White, L. J., & Dressendorfer, R. H. Included
(2004). Exercise and multiple
sclerosis. Sports Medicine, 34(15),
1077–1100.

Focuses on physiology alteration with
exercise implementation in patients with
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Appendix 4
Literature Review Table of All Studies Included
Citation

Study
Purpose

Pop
(N),
Sample
Size

Design/L
evel of
Evidence

Variables

Findings

Conclusion

Amatya, B.,
Young, J.,
Khan, F., &
Amatya, B.
(2018).

Investigate 10
the
Studies
effectivenes
s of nonpharmacolo
gical
therapies
for chronic
pain for
patients
with MS
(PwMS)

Level I

Nonpharmacolo
Literature
gical
review of
therapies
all
for chronic
published
pain such as
RCTs and
transcutane
CCTs
ous
electrical
nerve
stimulation
(TENS),
heat or cold
therapy,
supportive
braces,
exercise,
biofeedback
, and
relaxation

No
statistically
significant
association
for nonmedication
treatment for
chronic pain
management
for PwMS

Many
studies
contained
low number
of
participants
. More
research
needs to be
conducted
with more
participants
to
determine
effectivenes
s

Amatya, B.,
Khan, F.,
La Mantia,
L.,
Demetrios,
M., Wade,
D. T., &
Amatya, B.
(2013).

Investigate 9
effectivenes Studies
s of nonpharmacolo
gical
therapies
for
spasticity
for PwMS
including
TENS and
exercise

Level I

No statistical
significance
for nonpharmacolog
ical
treatment for
spasticity for
PwMS

Wide
variety of
nonpharmacolo
gical
methods are
used for
spasticity,
but more
through
trials need
to be done
to build
evidence

RCTs
using
GRADE
tool as
metaanalysis
was not
possible
due to
heterogen
eity of

Nonpharmacolo
gical
therapies
for
spasticity

31

included
studies
Bennett, M.
H., Heard,
R., &
Bennett, M.
H. (2011).

Investigate
efficacy
and safety
of
Hyperbaric
oxygen
therapy for
treatment of
MS

10
studies,
504
particip
ants

Level I

Brenner P,
Piehl F.
(2016).

Compare
pharmacolo
gical versus
nonpharmacolo
gical
therapy for
fatigue and
depression
in PwMS

NA

Level IV

Heydarpour
, P.,
Manoucheh
rinia, A.,
Beiki, O.,
Mousavi, S.
E.,
Abdolalizad
eh, A.,
Lakeh, M.
Moradi, &
Sahraian,

Investigate
environmen
tal factors,
focusing on
smoking, to
alter the
physiology
of MS

11
articles

RCTs
metaanalysis

Cohort
Study

Level I
Metaanalysis

for
spasticity
Hyperbaric
oxygen
therapy
versus sham
therapies
for MS

No statistical
significance
to verify a
benefit for
hyperbaric
oxygen
therapy for
treatment of
MS

Hyperbaric
oxygen
therapy
cannot be
justified for
routine
treatment
for MS

Pharmacolo
gical versus
nonpharmacolo
gical
treatment
for fatigue
and
depression
for PwMS

Pharmacolog
ical
treatment for
fatigue is
modest, nonpharmacolog
ical benefit
demonstrates
some
efficacy
although not
statistically
significant.
Very few
studies are
conducted on
depression.

Further
research is
needed to
refine
treatment
protocols.

Smoking
cessation
and
decreased
expanded
disability
status scale
(EDSS) and
multiple
sclerosis
severity
scale
(MSSS)

Smoking
increased
EDSS
however it
had no effect
on MSSS or
T2 lesion
volume

Insignifican
t findings
were
contributed
to a small
number of
studies,
different
study
techniques,
and
variations

32

M. A.
(2018).

in disability
reports.

Jakimovski,
D.,
WeinstockGuttman,
B., Gandhi,
S., Guan,
Y.,
Hagemeier,
J.,
Ramasamy,
D. P.,
Fuchs, T.,
Browne, R.,
Bergsland,
N., Dwywe,
M.,
Ramanathan
, M.,
Zivadinov,
R. (2019).

Assess
lifestyle
risk factors
linked to
cardiovascu
lar disease
and MS
outcomes

175
PwMS

Marck, C.
H., De
Livera, A.
M., Brown,
C. R.,
Neate, S. L.,
Taylor, K.
L., Weiland,
T. J.,
Hadgkiss,
E., Jelinek,
G. A.
(2018).

Assess
95
adopting
PwMS
and
adhering to
lifestyle
modificatio
n
intervention
s long-term

Level IV

Matveeva,
O., Bogie, J.
F. J.,
Hendriks, J.
J. A.,

Study
environmen
tal factors
and dietary
habits and

Level V

42
controls

NA

Level II
Single
RCT

Cohort
Study

MetaSynthesis

Followed
patients for
5 years,
obtained
baseline
and followup MRIs
and
assessed
changes
based on
diet and
lifestyle
changes

Lifestyle
contributes
to increased
and
enhanced
brain atrophy
in PwMS

Lifestyle
modificatio
ns may
prove to be
beneficial
for PwMS
and
reducing
the effect
and
potential
for brain
atrophy

Follow
PwMS for 1
year and 3
year followups from a
5 day
workshop
on lifestyle
modificatio
ns to assess
PwMS
physical
and mental
health

Decrease in
disability
from
baseline to 1year and 3year followup. Fewer
patients had
relapses
when
continuing
healthy
lifestyle
interventions

Lifestyle
modificatio
n that is
sustainable
is beneficial
to PwMS. It
may also
decrease
the need for
pharmacolo
gical
therapy

Assess how
the
westernized
diet and
disturbance

The
advancement
of molecular
mechanisms
that drive

A
westernized
lifestyle
contributes
to the risk

33

Linker, R.
A.,
Haghikia,
A., &
Kleinewietf
eld, M.
(2018).

the
correlation
between
MS
developmen
t

Neven, A.,
Vanderstrae
ten, A.,
Janssens,
D., Wets,
G., & Feys,
P. (2016).

Assess step 64
count,
PwMS
intensity,
and
duration of
walking in
correlation
to degree of
disability of
PwMS

Level II

Assess
pharmacolo
gical and
nonpharmacolo
gical
treatment
approaches
to fatigue
caused by
MS

Level V

Pozzilli, C.,
Sbardella,
E., de
Giglio, L.,
&
Tomassini,
V. (2006).

NA

RCT

s in the
sleep
circadian
rhythm to
understand
the etiology
of MS

MS can lead
to
specialized
dietary
treatment
approaches

assessment
for PwMS.
However,
more
research is
needed to
increase the
understandi
ng on why
that occurs

Assess
PwMS step
count,
duration
and
distance
over a
2,3,6,10,12,
14

Step count in
PwMS was
lower than
the
recommenda
tions, which
negatively
influenced
disability
scores

PwMS
should be
encouraged
to step at a
moderate
intensity for
longer
periods of
time to
decrease
their degree
of
disability.

Treatment
for fatigue
related to
MS should
be
approached
from a
multifactoria
l perspective
incorporating
pharmacolog
ical and nonpharmacolog
ical
treatment
approaches

In patients
with mild
fatigue due
to MS,
yoga,
aerobic
exercises,
cooling
therapy,
and energy
conservatio
n are best
paired with
pharmacolo
gical
treatments
for

minute
period

MetaSynthesis

Assess
different
pharmacolo
gical
approaches
to treatment
in
combinatio
n to nonpharmacolo
gical
treatment
approaches

34

decreased
fatigue.
Strober, L.
B., Becker,
A., &
Randolph,
J. J. (2018).

Assess if
daily
activities
can be used
as an
adjunct
therapy to
reduce
severity of
MS
symptoms

248
PwMS

Level II

White, L. J.,
&
Dressendorf
er, R. H.
(2004).

Investigate
formal
exercise
and
lifestyle as
early
treatment
approaches
to treatment
for PwMS

NA

Level I

RCT

RCTs

Assess if
healthy
nutrition,
exercise,
and social
engagement
impacts
function for
PwMS

Engaging in
positive
lifestyle
activities
have positive
effects on
MS and
disease
management

A holistic
approach to
treating MS
is best as it
considers
varying
aspects of
patient
functioning
and helps to
achieve the
overall goal
of optimal
health for
those living
with MS
using
exercise
and
temperature
control

Implementi
ng exercise
programs
that are
designed to
increased
fitness,
muscle
strength,
and
mobility

Early
implementati
on of
exercise for
PwMS to
reduce
increased
function
decline

Contrary to
the
previous
belief that
exercise
would
magnify
MS related
symptoms,
it is now
shown to be
beneficial
for PwMS
to be active
to promote
better
overall
health and
delayed

35

disease
progression
.

